The FBG receives € 150,000 from the AECC for childhood cancer research Blog Post

The project on neuroblastoma led by Elisa Martí Gorostiza, researcher at the Institute of Molecular Biology of Barcelona (IBMB-CSIC), based at PCB, and the Catalan Biotechnology Reference Network (XRB), has received one of the three grants for research projects on childhood cancer funded by the Spanish Association Against Cancer (AECC). The € 150,000 grant, obtained with the collaboration of the XRB, will be managed by the Bosch i Gimpera Foundation (FBG).

 

The Barcelona Science Park has strong presence at BIO-Europe Spring Blog Post

BIO-Europe Spring (BES) –the spring edition of the most important partnering congress in the biotechnology and pharmaceutical industry in Europe– returns to Barcelona in 20-22 March 2017 at the CCIB Convention Centre. After the success of the 2010 and 2013 editions, more than 100 companies and organizations from the BioRegion will be participating in the fair, twice as many as the previous year. This edition features remarkable presence of the Barcelona Science Park (PCB) and a large number of companies and entities from PCB Community.

 

CataloniaBio grants the ‘BioSuccess of the Year’ award to STAT-Diagnostica Blog Post

The Catalan Association of Biotechnology Companies (CataloniaBio) has recognized Stat-Diagnostica –founded in 2010 at the Barcelona Science Park by Jordi Carrera and Rafael Bru– with the ‘Biosuccess of the Year’ Award. The prize giving ceremony was held yesterday at the Museu Maritimo of Barcelona under his winter networking event CataloniaBio Gala Dinner, a yearly meeting organised by this business association with the aim of enhancing scientific-business cooperation in Catalonia in the field of life sciences and health.

 

New research front to tackle Friedreich’s Ataxia Blog Post

The associations of patients and families Babel Family and the Asociación Granadina de la Ataxia de Friedreich (ASOGAF) channel 80,000 euros of their donations (50% from each organisation) into a new 18-month project at the Institute for Research in Biomedicine (IRB Barcelona) located at PCB. The long-term goal of the project is to achieve an injectable frataxin treatment able to reach the brain. Frataxin is the protein that is reduced in those affected by this rare and degenerative disease, which has no cure.

 

Researchers find a gene that causes Opitz C syndrome in the only patient diagnosed in Catalonia Blog Post

A team led by the professors Daniel Grinberg and Susana Balcells, from the Institute of Biomedicine of the University of Barcelona (IBUB) at the Barcelona Science Park has identified a gene that causes the Opitz C syndrome in the only patient in Catalonia diagnosed with this genetic disease  which, so far, does not offer treatment possibilities, prenatal diagnosis or genetic counseling. This new scientific advance is a first step to discover the genetic bases of this congenital disease, that causes severe disabilities in patients and has been diagnosed in three people in the Iberian Peninsula, and sixty people in the world.  

 

Researchers from CNAG-CRG show that cryopreservation increases the scope of single cell sequencing Blog Post

Researchers from the Centro Nacional de Análisis Genómico (CNAG-CRG) at the Barcelona Science Park have substantially broadened the applicability of single cell genomics by combining cell and tissue cryopreservation with workflows of this emerging research field. According to the study, published in Genome Biology, cryopreserved material can be readily combined with conventional single cell sequencing methods and the authors foresee its implementation as standard technique in this type of analysis.

 

A new therapeutic target that could slow the progression of Parkinson’s disease Blog Post

Researchers from IBEC at PCB have identified a potential way to slow down the neurodegenerative progression of Parkinson’s disease. This breakthrough –a result of a collaboration of three research groups at IBEC together with colleagues in the Tòquio Metropolitan Institute of Medical Science, the Bellvitge University Hospital (HUB), the Vall d’Hebron Institute of Research (VHIR) and the Aragón Institute for Engineering Research (I3A)– could also apply to other types of neurodegenerative diseases, including some types of dementia such as Alzheimer’s disease, or multiple system atrophy.

 

Researchers from the URV, CIBERDEM and IRB Barcelona have developed a new technique to study the metabolism Blog Post

A group of researchers from IRB Barcelona at PCB, the URV and CIBERDEM have developed a new methodology that uses Nuclear Magnetic Resonance (NMR) to study cell metabolism. It is a tool that makes it possible to monitor metabolic fluxes and, in just 10 minutes, provide dynamic information about a considerable number of molecules. It may be able to be used in future applications to understand the reasons why some diseases develop.

 

El Parc Científic de Barcelona participa al YoMo amb múltiples propostes Blog Post

El Parc Científic de Barcelona (PCB) participa activament a la  primera edició del Youth Mobile Festival (YoMo) que avui obre les seves portes al recinte Montjuïc de Fira Barcelona, en el marc del Mobile World Congress. Durant quatre dies, el YoMo rebrà la visita de uns 20.000 escolars de Catalunya i Espanya, en una enorme exposició de ciència i tecnologia, amb espectacles de teatre en viu, tallers interactius i altres propostes per inspirar a milers de joves i apropar-los a les carreres professionals de l’ecosistema mòbil i STEAM (Science, Technology, Engineering, Arts and Mathematic).